IEFM
IQ EQ Fund Management Portfolio holdings
AUM
$1.12B
This Quarter Return
+16.87%
1 Year Return
+30.08%
3 Year Return
+73.97%
5 Year Return
+117.57%
10 Year Return
–
AUM
$432M
AUM Growth
+$432M
(+29%)
Cap. Flow
+$53.7M
Cap. Flow
% of AUM
12.43%
Top 10 Holdings %
Top 10 Hldgs %
30.71%
Holding
232
New
38
Increased
79
Reduced
61
Closed
6
Top Buys
| 1 |
iShares S&P Small-Cap 600 Growth ETF
IJT
|
$24.9M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$13M |
| 3 |
Roper Technologies
ROP
|
$2.41M |
| 4 |
Clorox
CLX
|
$2.33M |
| 5 |
Alibaba
BABA
|
$1.61M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$13.1M |
| 2 |
JPMorgan Chase
JPM
|
$3.38M |
| 3 |
Mondelez International
MDLZ
|
$2.71M |
| 4 |
Apple
AAPL
|
$2.61M |
| 5 |
CoStar Group
CSGP
|
$971K |
Sector Composition
| 1 | Technology | 34.91% |
| 2 | Financials | 12.22% |
| 3 | Healthcare | 11.68% |
| 4 | Industrials | 8.71% |
| 5 | Consumer Discretionary | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cintas
CTAS
$83.2B
| $274K | 0.06% |
775
| – | – |
|
202
Robert Half
RHI
$3.74B
| $274K | 0.06% |
4,381
| – | – |
|
203
Waters Corp
WAT
$17.4B
| $272K | 0.06% |
1,098
| – | – |
|
204
Strategic Education
STRA
$1.96B
| $268K | 0.06% |
+2,814
| New | +$268K |
|
205
Regeneron Pharmaceuticals
REGN
$60.8B
| $264K | 0.06% |
546
| – | – |
|
206
Skyworks Solutions
SWKS
$10.7B
| $264K | 0.06% |
1,730
-1,065
| -38% | -$163K |
|
207
Biogen
BIIB
$20.1B
| $262K | 0.06% |
1,068
| – | – |
|
|
TVRD
208
Tvardi Therapeutics, Inc. Common Stock
TVRD
$280M
| $260K | 0.06% |
+17,184
| New | +$260K |
|
209
Illumina
ILMN
$15.2B
| $255K | 0.06% |
688
| – | – |
|
210
CBRE Group
CBRE
$47.3B
| $248K | 0.06% |
+3,949
| New | +$248K |
|
211
Snap-on
SNA
$16.8B
| $248K | 0.06% |
1,448
| – | – |
|
212
Philip Morris
PM
$260B
| $247K | 0.06% |
2,984
+194
| +7% | +$16.1K |
|
213
Netflix
NFLX
$511B
| $241K | 0.06% |
+446
| New | +$241K |
|
|
ZYNE
214
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $238K | 0.06% |
72,169
+40,617
| +129% | +$134K |
|
215
Incyte
INCY
$16.9B
| $234K | 0.05% |
2,689
| – | – |
|
216
lululemon athletica
LULU
$23.6B
| $233K | 0.05% |
669
-94
| -12% | -$32.7K |
|
217
Marsh & McLennan
MMC
$101B
| $232K | 0.05% |
1,986
| – | – |
|
218
Lennox International
LII
$19.2B
| $226K | 0.05% |
825
| – | – |
|
219
Equinix
EQIX
$75.3B
| $224K | 0.05% |
313
| – | – |
|
220
Stride
LRN
$7.05B
| $223K | 0.05% |
+10,526
| New | +$223K |
|
221
ConocoPhillips
COP
$123B
| $219K | 0.05% |
5,488
-1,640
| -23% | -$65.4K |
|
222
Hormel Foods
HRL
$13.9B
| $214K | 0.05% |
4,599
| – | – |
|
223
Lifecore Biomedical
LFCR
$279M
| $209K | 0.05% |
+19,235
| New | +$209K |
|
224
Teva Pharmaceuticals
TEVA
$21.2B
| $167K | 0.04% |
+17,301
| New | +$167K |
|
225
cbdMD
YCBD
$6.9M
| $145K | 0.03% |
49,248
+27,717
| +129% | +$81.6K |
|